QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

SAN DIEGO, CALIFORNIA / ACCESS Newswire / October 14, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW), a leader in AI-powered sc...

Core News & Articles

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, ...

Core News & Articles

Patented AI Olfaction Platform Targets Semiconductor, Smart Factory, and Hospital Markets With First Deployments UnderwaySmellT...

Core News & Articles

Advancing a Novel, Side-Effect-Free Treatment for a Rare Yet Widely Underserved Autoimmune Disease

Core News & Articles

Seven-Site Pilot Spanning Pharma, Facility Management, Energy and Utilities to Validate AI Nose as Next-Gen Industrial AI at Sc...

Core News & Articles

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization,...

Core News & Articles

AI Nose and Smell Language Model Combine with Solomon's Vision AI to Power Multi-Sensory AutomationPartnership Accelerates ...

Core News & Articles

Partners With ASE to Scale AI Nose Deployment and Set New Standard in Intelligent SensingAchieves Strategic Inflection Point in...

Core News & Articles

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") , a leader in AI-driven scent digitization, ...

Core News & Articles

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it will implement a con...

Core News & Articles

A Major Breakthrough in Ainos' Mission to Digitize ScentFirst-ever Smell-Enabled Robotics Will Unlock New Revenue Streams i...

Core News & Articles

Sjogren's Syndrome is a rare autoimmune disease with limited treatment optionsPrior U.S. Phase 3 data demonstrated benefits...

Core News & Articles

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company"), a diversified medtech company focused on t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION